SCHEMBL5358079

SCHEMBL5358079

O=C1NC(=O)C2(CCC(c3ccccc3)CC2)N1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CRBN Q96SW2 4/20 0.49
ADAMTS5 Q9UNA0 5/20 0.44
DDB1 Q16531 1/20 0.43
SLC18A3 Q16572 1/20 0.43
SIGMAR1 Q99720 1/20 0.43
AKR1A1 P14550 1/20 0.43
AKR1B1 P15121 1/20 0.43
CACNA1F O60840 1/20 0.41
ALDH1A1 P00352 1/20 0.41
MAPT P10636 1/20 0.41
CYP2C9 P11712 1/20 0.41
HTR2A P28223 1/20 0.41
HRH1 P35367 1/20 0.41
SCN1A P35498 1/20 0.41
SCN4A P35499 1/20 0.41
BLM P54132 1/20 0.41
PMP22 Q01453 1/20 0.41
CACNA1D Q01668 1/20 0.41
KCNH2 Q12809 1/20 0.41
CACNA1S Q13698 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14117525 1.00 CRBN (0.49) CRBNADAMTS5DDB1SLC18A3SIGMAR1
SCHEMBL7070786 0.90 CRBN (0.43) CRBNADAMTS5DDB1AKR1A1AKR1B1
SCHEMBL14117579 0.85 HTT (0.41) CRBNADAMTS5AKR1A1AKR1B1
SCHEMBL14117544 0.84 ESR2 (0.54) CRBNAKR1B1CYP2C9
SCHEMBL14117593 0.84 ADAMTS5 (0.46) CRBNADAMTS5AKR1A1AKR1B1ALDH1A1
SCHEMBL14117530 0.80 ALDH1A1 (0.46) CRBNDDB1ALDH1A1HTR2A
SCHEMBL14117606 0.79 HTR2C (0.55) CRBNDDB1HTR2A
SCHEMBL14117536 0.77 MMP12 (0.43) CRBNALDH1A1MAPTKCNH2
SCHEMBL14117553 0.77 TSHR (0.49) ADAMTS5
SCHEMBL19284716 0.76 MTNR1A (0.47) CRBNDDB1ALDH1A1MAPTBLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230174540-A1 3-(Carboxymethyl)-8-Amino-2-Oxo-1,3-Diaza-Spiro-[4.5]-Decane Derivatives GRUENENTHAL GMBH (DE) 2023-06-08 US disclosed
WO-2007103719-A2 MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME INCYTE CORPORATION (US) 2007-09-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230174540-A1 3-(Carboxymethyl)-8-Amino-2-Oxo-1,3-Diaza-Spiro-[4.5]-Decane Derivatives OPRK1, OPRD1, PKD2 CRBN 2244/4885ADAMTS5 3089/4885DDB1 167/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.